Summary
This is a National Institutes of Health (NIH) funding opportunity announcement (PA-24-253) for a Successor-in-Interest (Type 6) grant, with a Parent Clinical Trial Optional designation. A Type 6 activity code is used when an applicant organization is taking over an existing NIH grant from another organization (successor-in-interest), allowing continuation of previously funded research. The clinical trial optional designation means applicants may or may not include a clinical trial component. The opportunity has a multi-year open window running from July 2024 through July 2027.